Background and aim of the study: Outcomes of emergency coronary artery bypass grafting (CABG) for acute coronary syndrome (ACS) due to left main coronary (LM) disease remain unclear. This study aims to assess the short term Outcome for patients undergoing Urgent CABG, due to LM disease; as assessed by relief of symptoms and 6 months improvement of EF.
Methods:This study included 60 patients that underwent urgent coronary artery bypass grafting. Patients were divided into three groups according to the pre operative ejection fraction (EF). The three groups were compared regarding preoperative, operative, and postoperative Echo measurement of Ejection fraction and relief of symptoms.Results: 70% of our cases were male with mean age of 52.2 yr (range, ±7.19 years), no clinical significance between preoperative comorbidities in relation between 3 groups and the postoperative outcome, the risk factors for our patients are Preoperative myocardial infarction (MI), hemodynamic (HD) instability specially in group C and in turn intraoperative risk is; prolonged Cardiopulmonary bypass time and cross clamp time, while during the intensive care unit stay; postoperative bleeding, MI, prolonged ventilation time and extended ICU stay. The total mortality rate is 8.3% form our patients. Postoperative echocardiography just before discharge and 6 months later showed significant improvement of EF especially for patient showing preoperative instability and MI.
Conclusion:The present study demonstrated that patients undergoing Urgent CABG have a significant higher preoperative risk especially with myocardial impairment, despite the higher mortality rate 12%, a favorable clinical outcome can be expected if patients survive.
Future fertility after ectopic pregnancy is dependent on several factors, including age, history of infertility, history of previous EP, tubal rupture, and contralateral tubal lesion. Thus, it seems reasonable to assess tubal patency following a treatment of an ectopic pregnancy in those women who are willing to have future pregnancy. Aimed to: Compare between tubal patency after methotrexate & laparoscopic salpingostomy. The study included 72 patients equally divided in number into 2 main groups. First group: (36cases) Tubal ectopic pregnancy treated by MXT therapy single or multiple doses. Single dose regimen (MTX 1.0 mg/kg or 50 mg/m2 i.m or multiple dose regimen (MTX 1.0 mg/kg i.m days (0,2,4,6). Second group: - (36 cases) Tubal ectopic pregnancy treated by laparoscopic salpingostomy. After 3 months, we used laparoscopy with administration of methylene blue (MB) as a marker to detect the tubal patency. As regard to tubal patency, of 31 cases (86.1%) from 36 cases that treated by MTX were patent and 5 cases (13.9 %) were blocked. On the other side 21 cases (58.3 %) from 36 cases that treated by laparoscopic salpingostomy were patent and 15 cases (41.7 %) were blocked). Conclusions:Methotrexate is better than laparoscopic salpingostomy in treating undisturbed tubal pregnancy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.